LeMaitre Vascular
LMAT | NASDAQ
$77.01
-$1.28 (-1.63%)
At close: Nov 16, 2026, 4:00 PM ET
$77.01
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
LeMaitre Vascular Company Profile
Company profile explainedCompany Profile
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| George W. LeMaitre | Chairman & Chief Executive Officer |
| Dorian LeBlanc | Chief Financial Officer |
| Laurie A. Churchill | Chief Legal Officer |
| Daniel J. Mumford | Senior Director of Human Resources |
| David Roberts | President & Director |
| George D. LeMaitre FACS | Founder and Chairman of Scientific Advisory Board |
| Jonathan W. Ngau | Senior Vice President of Information Technology |
| Kimberly L. Cieslak | Vice President of Marketing |
| Maik D. Helmers | Senior Vice President of Sales Central Europe |
| Trent G. Kamke | Senior Vice President of Operations |
LeMaitre Vascular
| Country | United States |
| IPO Date | Oct 19, 2006 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 651 |
| CEO | George W. LeMaitre |
Contact Details
63 Second Avenue Burlington,
Massachusetts 01803 United States
Stock Details
| Ticker Symbol | LMAT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001158895 |
| CUSIP Number | 525558201 |
| ISIN Number | US5255582018 |
| SIC Code | 3841 |
Recent News
- 10 days ago / seekingalpha.comLeMaitre Vascular, Inc. (LMAT) Q3 2026 Earnings Call Transcript
- 10 days ago / globenewswire.comLeMaitre to Participate in Upcoming Investor Conferences
- 12 days ago / marketbeat.comLeMaitre Vascular Q3 Earnings Call Highlights
- 12 days ago / zacks.comLeMaitre Vascular (LMAT) Misses Q3 Earnings Estimates
- 1 month ago / globenewswire.comLeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
- 2 months ago / seekingalpha.comLeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine
- 3 months ago / globenewswire.comLeMaitre to Participate at Upcoming Investor Conferences in September
- 3 months ago / seekingalpha.comLeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut
- 3 months ago / globenewswire.comLeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
- 3 months ago / seekingalpha.comLeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript
Add to Watchlist
Select watchlists to add or remove LMAT